Fischer C, Chen S-S, Nimmerfroh J, Eugster A, Stücheli S, Schultheiß C, Widmer C, Heim D, Kasenda B, Passweg J, Kobold S, Egli L, Coianiz N, Chijioke O, Chiorazzi N, Follo M, Läubli H, Peipp M, Binder M. IGLV3-21<sup>R110</sup&gt;-directed bispecific antibodies activate T cells and promote killing in a high-risk subset of chronic lymphocytic leukemia. Haematologica 2026;111(2):572-582; https://doi.org/10.3324/haematol.2025.287697.